Occudo Quantitative Strategies’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,223
Closed -$252K 1117
2023
Q3
$252K Buy
+5,223
New +$310K 0.03% 730
2023
Q2
Sell
-4,796
Closed -$232K 1234
2023
Q1
$232K Sell
4,796
-8,169
-63% -$432K 0.02% 714
2022
Q4
$781K Sell
12,965
-25,924
-67% -$1.52M 0.09% 362
2022
Q3
$2.36M Buy
+38,889
New +$1.23M 0.18% 150

Other funds holding PRTA

Occudo Quantitative Strategies's PRTA Position: Q4 2023 in Review

Occudo Quantitative Strategies sold out of Prothena Corp (PRTA) in Q4 2023, closing a stake of 5,223 shares — an estimated $252K sold.

Occudo Quantitative Strategies first reported a position in PRTA in Q3 2022 and held it in 4 quarters. The position peaked at $2.36M in Q3 2022. 187 funds tracked by Wall St. Rank hold PRTA as of Q4 2023.

  • Occudo Quantitative Strategies reported no remaining Prothena Corp position as of Q4 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 5,223 Prothena Corp shares in Q4 2023, an estimated $252K.
  • Occudo Quantitative Strategies first reported a position in Prothena Corp in Q3 2022 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Prothena Corp position peaked at $2.36M in Q3 2022.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.